Charles River
CRL
300.30
-4.66
-1.53%
Charles River
US · CRL
#1174 by market cap
Listed 1970
300.30
-4.66
-1.53%
Live - 5344 symbols - heartbeat 434s ago
· 2026-10-08 07:05
Pre-market
299.00
-0.43%
After-hours
300.30
0.00%
- Market cap
- 14.34B
- P/E (TTM)i
- -62.56
- P/Bi
- 5.05
- EPSi
- -2.91
- Div yieldi
- 0.00%
- 52W posi
- 82%
Reader sentiment
Are you bullish or bearish on CRL?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 15 analysts
Buy
Avg price target
319.85 +6.5%
Price target rangecurrent 300.30
Low265.00
Avg319.85
High357.00
Buy 93%
Hold 7%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | UBS | -- | BUY | 357.00 |
| 2026-09-28 | BofA Securities | -- | BUY | -- |
| 2026-09-28 | Jefferies | -- | BUY | 340.00 |
| 2026-09-25 | TD Cowen | -- | BUY | 325.00 |
| 2026-09-25 | Mizuho Securities | -- | HOLD | 295.00 |
| 2026-09-25 | Baird | -- | BUY | 334.00 |
| 2026-09-25 | Evercore | -- | BUY | 330.00 |
| 2026-09-25 | Deutsche Bank | -- | BUY | 320.00 |
| 2026-09-25 | RBC Capital | -- | BUY | 322.00 |
| 2026-09-24 | TD Cowen | -- | BUY | 325.00 |
| 2026-09-24 | William Blair | -- | BUY | -- |
| 2026-09-24 | Barclays | -- | BUY | 330.00 |
| 2026-09-21 | Morgan Stanley | -- | BUY | 300.00 |
| 2026-09-16 | Argus Research | -- | BUY | 330.00 |
| 2026-09-16 | RBC Capital | -- | BUY | 282.00 |
| 2026-09-14 | Morgan Stanley | -- | BUY | 300.00 |
| 2026-09-11 | Evercore | -- | BUY | 320.00 |
| 2026-08-10 | TD Cowen | -- | BUY | 300.00 |
| 2026-08-09 | TD Cowen | -- | BUY | 300.00 |
| 2026-08-06 | Baird | -- | BUY | 291.00 |
| 2026-08-06 | Morgan Stanley | -- | BUY | 300.00 |
| 2026-08-06 | Evercore | -- | BUY | 300.00 |
| 2026-08-06 | Deutsche Bank | -- | BUY | 300.00 |
| 2026-08-05 | TD Cowen | -- | BUY | 235.00 |
| 2026-08-05 | William Blair | -- | BUY | -- |
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Buy
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
4
■ Upgrades■ Downgrades
- 4 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: UBS moved from Hold to Buy on 2026-09-30.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-30 | UBS | HOLD → BUY | 357.00 |
| 2026-06-17 | Morgan Stanley | HOLD → BUY | 220.00 |
| 2025-12-15 | BofA Securities | HOLD → BUY | 225.00 |
| 2025-11-06 | Baird | HOLD → BUY | 199.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | -- | ±10.93% | +11.36% (beat) |
| 2026/Q1 | 2026-05-07 | -- | ±9.13% | -0.03% (in line) |
| 2025/Q4 | 2026-02-18 | -- | ±11.77% | -0.33% (in line) |
| 2025/Q3 | 2025-11-05 | -- | ±10.56% | -5.71% (in line) |
| 2025/Q2 | 2025-08-06 | -- | ±11.19% | -10.25% (in line) |
| 2025/Q1 | 2025-05-07 | -- | ±12.22% | +18.68% (beat) |
| 2024/Q4 | 2025-02-19 | -- | ±7.82% | +6.87% (in line) |
| 2024/Q3 | 2024-11-06 | -- | ±10.72% | +13.53% (beat) |
| 2024/Q2 | 2024-08-07 | -- | ±9.66% | -12.60% (beat) |
| 2024/Q1 | 2024-05-09 | -- | ±8.30% | -2.21% (in line) |
| 2023/Q4 | 2024-02-14 | -- | ±7.64% | +11.30% (beat) |
| 2023/Q3 | 2023-11-08 | -- | ±8.68% | -3.74% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:05:05 · For reference only, not investment advice and not tailored to your situation.